Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and <i>In Vitro</i> Experiments-Reference-Cited by-同舟云学术

Nobiletin Inhibits Breast Cancer Stem Cell by Regulating the Cell Cycle: A Comprehensive Bioinformatics Analysis and In Vitro Experiments

Published:2024-05-09 Issue:7 Volume:76 Page:638-655
ISSN:0163-5581
Container-title:Nutrition and Cancer
language:en
Short-container-title:Nutrition and Cancer

Author:

Hermawan Adam¹²³^ORCID,Ikawati Muthi¹²^ORCID,Putri Dyaningtyas Dewi Pamungkas²³⁴^ORCID,Fatimah Nurul³,Prasetio Heri Himawan¹

Affiliation:

1. Laboratory of Macromolecular Engineering, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, Yogyakarta, Indonesia

2. Cancer Chemoprevention Research Center, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, Yogyakarta, Indonesia

3. Laboratory of Advanced Pharmaceutical Sciences. APSLC Building, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, Yogyakarta, Indonesia

4. Laboratory of Pharmacology and Toxicology, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada Sekip Utara II, Yogyakarta, Indonesia

Funder

Research Grant from the Ministry of Education, Culture, Research, and Technology through the Research Project PDUPT

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/01635581.2024.2348217

Reference94 articles.

1. Current and future burden of breast cancer: Global statistics for 2020 and 2040

2. Risk for relapse and death after adjuvant chemotherapy associated with SNPs in patients with breast cancer - A retrospective study.

3. The lingering mysteries of metastatic recurrence in breast cancer

4. Isolation and characterization of breast cancer stem cell‐like phenotype by Oct4 promoter‐mediated activity

5. Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review